Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Fiserv president resigns, interim leaders named for financial unit
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Gilead Sciences (GILD) Tops Q4 EPS by 4c, Offers FY Guidance
February 4, 2021 4:03 PM ESTGilead Sciences (NASDAQ: GILD) reported Q4 EPS of $2.19, $0.04 better than the analyst estimate of $2.15. Revenue for the quarter came in at $7.42 billion versus the consensus estimate of $7.33 billion.
GUIDANCE:
Gilead Sciences sees FY2021 EPS of $6.75-$7.45, versus the consensus of... More
